Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a complex couplet care intervention in a neonatal intensive care unit: A mixed methods study protocol.

Pediatric investigation·2024
Same author

Denmark: Health System Review.

Health systems in transition·2024
Same author

Balancing financial incentives during COVID-19: A comparison of provider payment adjustments across 20 countries.

Health policy (Amsterdam, Netherlands)·2021
Same author

Nordic responses to Covid-19: Governance and policy measures in the early phases of the pandemic.

Health policy (Amsterdam, Netherlands)·2021
Same author

Depletion of CD45RA<sup>+</sup> T cells: Advantages and disadvantages of different purification methods.

Journal of immunological methods·2021
Same author

Inter-professional agreement and collaboration between extended scope physiotherapists and orthopaedic surgeons in an orthopaedic outpatient shoulder clinic - a mixed methods study.

BMC musculoskeletal disorders·2021

Related Experiment Video

Updated: Jun 11, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Polypharmacy in general practice.

Kirsten Schaefer1, Henrik Maerkedahl, Hans Okkels Birk

  • 1Quality & Development, Region Zealand. kgs@regionsjaelland.dk

Danish Medical Bulletin
|July 2, 2010
PubMed
Summary
This summary is machine-generated.

Major polypharmacy (MPP), affecting 2.1% of the population, often involves medications lacking clear indications. Auditing patient prescriptions is crucial for improving medication management and patient safety.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Experiment Videos

Last Updated: Jun 11, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Area of Science:

  • Gerontology
  • Clinical Pharmacy
  • Public Health

Background:

  • Polypharmacy poses significant risks, including adverse drug events and interactions.
  • Quantifying the prevalence of major polypharmacy (MPP) is essential for understanding its impact on healthcare systems.
  • A quality improvement project was initiated to address MPP in a Danish county.

Purpose of the Study:

  • To determine the prevalence of major polypharmacy (MPP) in Roskilde County, Denmark.
  • To assess the quality of medication management for patients with MPP.
  • To evaluate the feasibility of a quality improvement project involving general practitioners (GPs).

Main Methods:

  • Prospective registry study of subsidized drug prescriptions in Roskilde County (Q3 2005).
  • Inclusion of 236,000 inhabitants.
  • Audit of medications for 220 MPP patients selected by participating GPs.

Main Results:

  • MPP patients represented 2.1% of the county's population.
  • GPs showed significant engagement in prescription auditing.
  • A substantial proportion of audited patients were on medications with outdated or questionable indications.

Conclusions:

  • Major polypharmacy challenges GPs' medication management capabilities.
  • Systematic auditing of comprehensive patient medication lists is recommended.
  • Implementing structured medication reviews can mitigate risks associated with polypharmacy.